SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Table: Tanvex BioPharma 3Q Net Loss NT$400.1M Vs NT$273.5M

Tanvex BioPharma Inc. - Taiwan 3rd Quarter ended Sept. 30: Figures in New Taiwan dollars. 2026 2025 Revenue NT$158,837,000 NT$125,337,000 Pretax Profit (NT$405,983,000) (NT$273,497,000) Net Profit…

6541

Related stories